News & Updates
Filter by Specialty:
Child abuse increased during COVID-19 lockdown
Child abuse rates appear to have increased during the lockdowns imposed to control COVID-19 transmission, according to a study from the US presented at the 2021 American Academy of Pediatrics National Conference & Exhibition (AAP 2021).
Child abuse increased during COVID-19 lockdown
30 Nov 2021Childhood cancers often misdiagnosed as TB, leads to more deaths
Cancer is frequently misdiagnosed as tuberculosis (TB) in children due to the clinical and radiologic overlap of the two diseases, which then contributes to increased mortality in this population, reveals a recent study.
Childhood cancers often misdiagnosed as TB, leads to more deaths
30 Nov 2021Repurposing a broad-spectrum antiviral drug may help treat asymptomatic, mild COVID-19
The oral antiviral drug umifenovir, which is used to treat influenza, appears to be beneficial in COVID-19 patients who are asymptomatic or with mild symptoms, with a phase III study showing that the drug is well tolerated and can induce viral clearance within 5 days.
Repurposing a broad-spectrum antiviral drug may help treat asymptomatic, mild COVID-19
29 Nov 2021No causal link between COVID-19 and atrial fibrillation
Patients with the coronavirus disease 2019 (COVID-19), even those genetically predisposed to the disease, are not at increased risk of developing atrial fibrillation, and vice versa, a study has found.
No causal link between COVID-19 and atrial fibrillation
29 Nov 2021Convalescent plasma ineffective for COVID-19
A recent Singapore meta-analysis of randomized controlled trials (RCT) has found no clear clinical benefit to using convalescent plasma (CP) for patients with the coronavirus disease 2019 (COVID-19), especially in those with severe disease.
Convalescent plasma ineffective for COVID-19
26 Nov 2021Single tocilizumab dose effectively suppresses systemic inflammation in COVID-19
A single injection of tocilizumab is enough to weaken systemic inflammation for up to 7 days in patients with the coronavirus disease 2019 (COVID-19), a recent study suggests.
Single tocilizumab dose effectively suppresses systemic inflammation in COVID-19
25 Nov 2021Suboptimal influenza vaccination persists among insurance holders despite no copayment
The coverage of influenza vaccination for Medicare beneficiaries remains poor, reports a study, noting missed opportunities despite availability of vaccines with no copayment. In addition, there are still disparities in vaccination uptake by race/ethnicity.
Suboptimal influenza vaccination persists among insurance holders despite no copayment
24 Nov 2021Automated text messaging service helps reduce deaths in outpatients with COVID-19
Adults newly diagnosed with COVID-19 in outpatient settings and enrolled in an automated remote monitoring service are less likely to succumb to the disease potentially due to more frequent telemedicine encounters and earlier presentation to the emergency department (ED), a study has shown.